- Home
- APRE vs TKLF Comparison
APRE vs TKLF Comparison
Compare APRE & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APRE | TKLF |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 15.6M |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | APRE | TKLF |
|---|---|---|
| Price | $0.95 | $2.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 71.9K | 10.6K |
| Earning Date | 11-12-2025 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.57 |
| Revenue | $488,239.00 | ★ $210,119,238.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.62 |
| Revenue Growth | N/A | ★ 7.38 |
| 52 Week Low | $0.90 | $2.10 |
| 52 Week High | $5.00 | $4.32 |
Technical Indicators
Market Signals| Indicator | APRE | TKLF |
|---|---|---|
| Relative Strength Index (RSI) | 30.90 | 38.13 |
| Support Level | $0.90 | $2.28 |
| Resistance Level | $1.14 | $2.58 |
| Average True Range (ATR) | 0.09 | 0.23 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 8.98 | 52.88 |
Price Performance
Historical ComparisonAbout APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.